Assessing the applicability of the DOAC, HAS‐BLED and ORBIT risk scores in Chinese patients on non‐vitamin K antagonist oral anticoagulants
In a non-valvular AF Chinese patients receiving NOACs, the HAS-BLED score showed an ability to predict MB comparable to that of the DOAC score and superior to that of the ORBIT score. The DOAC score does not seem to be more suitable for Chinese patients than the HAS-BLED score.
Authors
- Yiyi Jin (ORCID: https://orcid.org/0000-0003-2984-1914)
- Xuan Yin
- Suyan Zhu (ORCID: https://orcid.org/0009-0001-3920-185X)
- Miao Fan (ORCID: https://orcid.org/0000-0002-6675-1195)
- Xiaomeng Zheng
Institutions
- Ningbo University (CN)
- China Pharmaceutical University (CN)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1111/bcp.16396
- Citations
- 4
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 5.55